Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.

Zhang, Cuijian; Qian, Jinqin; Wu, Yucai; Zhu, Zhenpeng; Yu, Wei; Gong, Yanqing; Li, Xuesong; He, Zhisong; Zhou, Liqun

Zhang, Cuijian; Qian, Jinqin; Wu, Yucai; Zhu, Zhenpeng; Yu, Wei; Gong, Yanqing; Li, Xuesong; He, Zhisong; Zhou, Liqun.

Afiliación

Zhang C; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Qian J; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Wu Y; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Zhu Z; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Yu W; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Gong Y; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Li X; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
He Z; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Zhou L; Department of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.

Pathol Oncol Res ; 27: 1609968, 2021.

Article en En | MEDLINE | ID: mdl-34646089

Asunto(s)

Biomarcadores de Tumor/genética; Tumores Neuroendocrinos/genética; Neoplasias de la Próstata Resistentes a la Castración/genética; Adenocarcinoma/genética; Adenocarcinoma/patología; Adulto; Anciano; Anciano de 80 o más Años; Carcinoma Neuroendocrino/genética; Carcinoma Neuroendocrino/patología; Progresión de la Enfermedad; Regulación Neoplásica de la Expresión Génica/genética; Humanos; Masculino; Persona de Mediana Edad; Tumores Neuroendocrinos/patología; Próstata/patología; Neoplasias de la Próstata Resistentes a la Castración/patología; Transcriptoma/genética

Palabras clave

LASSO; WGCNA; biomarker; mCRPC; neuroendocrine prostate cancer (NEPC); signature

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Tumores Neuroendocrinos / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google